ComPAS: a Bayesian drug combination platform trial design with adaptive shrinkage

DOI10.1002/sim.8026zbMATH Open1545.6259MaRDI QIDQ6625925

Ying Yuan, Jing Shen, Rui Tang

Publication date: 28 October 2024

Published in: Statistics in Medicine (Search for Journal in Brave)

zbMATH Keywords

immunotherapyBayesian hierarchical modelcombination therapyBayesian adaptive designplatform designadaptive information borrowing

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cites Work

• Bayesian phase I/II adaptively randomized oncology trials with combined drugs
• Bayesian Model Averaging Continual Reassessment Method in Phase I Clinical Trials
• BLAST: Bayesian latent subgroup design for basket trials accounting for patient heterogeneity

Related Items (1)

A Bayesian adaptive phase i/II platform trial design for pediatric immunotherapy trials

This page was built for publication: ComPAS: a Bayesian drug combination platform trial design with adaptive shrinkage